Van Cleef Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $690K | Sell |
4,950
-540
| -10% | -$75.6K | 0.07% | 75 |
|
|
2025
Q4 | $674K | Hold |
5,490
| – | – | 0.07% | 75 |
|
|
2025
Q3 | $609K | Hold |
5,490
| – | – | 0.06% | 77 |
|
|
2025
Q2 | $609K | Hold |
5,490
| – | – | 0.07% | 75 |
|
|
2025
Q1 | $615K | Sell |
5,490
-465
| -8% | -$48K | 0.07% | 74 |
|
|
2024
Q4 | $550K | Sell |
5,955
-315
| -5% | -$28.4K | 0.06% | 79 |
|
|
2024
Q3 | $526K | Sell |
6,270
-1,305
| -17% | -$99.6K | 0.06% | 83 |
|
|
2024
Q2 | $520K | Sell |
7,575
-2,290
| -23% | -$153K | 0.07% | 76 |
|
|
2024
Q1 | $723K | Sell |
9,865
-350
| -3% | -$26.9K | 0.09% | 67 |
|
|
2023
Q4 | $828K | Sell |
10,215
-200
| -2% | -$15.6K | 0.12% | 60 |
|
|
2023
Q3 | $781K | Sell |
10,415
-740
| -7% | -$56.9K | 0.12% | 59 |
|
|
2023
Q2 | $860K | Sell |
11,155
-170
| -2% | -$13.6K | 0.13% | 60 |
|
|
2023
Q1 | $940K | Sell |
11,325
-61,796
| -85% | -$5.12M | 0.15% | 60 |
|
|
2022
Q4 | $6.28M | Sell |
73,121
-1,142
| -2% | -$90.4K | 1.04% | 23 |
|
|
2022
Q3 | $4.58M | Sell |
74,263
-1,306
| -2% | -$82.4K | 0.89% | 28 |
|
|
2022
Q2 | $4.67M | Sell |
75,569
-1,418
| -2% | -$87.8K | 0.79% | 28 |
|
|
2022
Q1 | $4.58M | Sell |
76,987
-747
| -1% | -$47.8K | 0.66% | 30 |
|
|
2021
Q4 | $5.64M | Sell |
77,734
-1,799
| -2% | -$124K | 0.79% | 30 |
|
|
2021
Q3 | $5.55M | Sell |
79,533
-465
| -0.6% | -$32.7K | 0.84% | 29 |
|
|
2021
Q2 | $5.51M | Sell |
79,998
-4,330
| -5% | -$289K | 0.81% | 29 |
|
|
2021
Q1 | $5.45M | Sell |
84,328
-1,505
| -2% | -$97K | 0.85% | 28 |
|
|
2020
Q4 | $5M | Sell |
85,833
-3,294
| -4% | -$199K | 0.82% | 27 |
|
|
2020
Q3 | $5.63M | Sell |
89,127
-985
| -1% | -$68.3K | 1.05% | 26 |
|
|
2020
Q2 | $6.93M | Sell |
90,112
-252
| -0.3% | -$19.3K | 1.41% | 20 |
|
|
2020
Q1 | $6.76M | Sell |
90,364
-4,344
| -5% | -$300K | 1.66% | 17 |
|
|
2019
Q4 | $6.15M | Sell |
94,708
-24,154
| -20% | -$1.57M | 1.26% | 23 |
|
|
2019
Q3 | $7.53M | Sell |
118,862
-1,184
| -1% | -$77.4K | 1.66% | 20 |
|
|
2019
Q2 | $8.11M | Sell |
120,046
-895
| -0.7% | -$58.9K | 1.78% | 18 |
|
|
2019
Q1 | $7.86M | Sell |
120,941
-1,967
| -2% | -$131K | 1.82% | 17 |
|
|
2018
Q4 | $7.69M | Sell |
122,908
-9,198
| -7% | -$643K | 2.05% | 15 |
|
|
2018
Q3 | $10.2M | Sell |
132,106
-903
| -0.7% | -$68.2K | 2.28% | 13 |
|
|
2018
Q2 | $9.42M | Buy |
133,009
+362
| +0.3% | +$25.6K | 2.25% | 13 |
|
|
2018
Q1 | $10M | Buy |
132,647
+2,895
| +2% | +$230K | 2.47% | 11 |
|
|
2017
Q4 | $9.29M | Buy |
129,752
+63,096
| +95% | +$4.79M | 2.29% | 12 |
|
|
2017
Q3 | $5.4M | Buy |
66,656
+1,108
| +2% | +$84.7K | 1.47% | 24 |
|
|
2017
Q2 | $4.64M | Buy |
65,548
+1,927
| +3% | +$128K | 1.35% | 24 |
|
|
2017
Q1 | $4.32M | Sell |
63,621
-262
| -0.4% | -$18.4K | 1.31% | 24 |
|
|
2016
Q4 | $4.58M | Sell |
63,883
-74
| -0.1% | -$5.5K | 1.46% | 22 |
|
|
2016
Q3 | $5.06M | Buy |
63,957
+1,245
| +2% | +$101K | 1.68% | 20 |
|
|
2016
Q2 | $5.23M | Buy |
62,712
+915
| +1% | +$81.2K | 1.8% | 20 |
|
|
2016
Q1 | $5.68M | Buy |
61,797
+476
| +0.8% | +$42.9K | 2.01% | 14 |
|
|
2015
Q4 | $6.21M | Buy |
61,321
+566
| +0.9% | +$58.9K | 2.28% | 13 |
|
|
2015
Q3 | $5.97M | Buy |
60,755
+1,031
| +2% | +$115K | 2.36% | 12 |
|
|
2015
Q2 | $6.99M | Sell |
59,724
-836
| -1% | -$91.3K | 2.6% | 10 |
|
|
2015
Q1 | $5.94M | Sell |
60,560
-1,230
| -2% | -$125K | 2.21% | 12 |
|
|
2014
Q4 | $5.82M | Buy |
61,790
+14,210
| +30% | +$1.47M | 2.15% | 13 |
|
|
2014
Q3 | $5.07M | Sell |
47,580
-100
| -0.2% | -$9.79K | 2.08% | 15 |
|
|
2014
Q2 | $3.95M | Sell |
47,680
-6,783
| -12% | -$528K | 1.66% | 20 |
|
|
2014
Q1 | $3.86M | Buy |
54,463
+6,260
| +13% | +$491K | 1.69% | 20 |
|
|
2013
Q4 | $3.62M | Buy |
48,203
+2,300
| +5% | +$160K | 1.59% | 20 |
|
|
2013
Q3 | $2.89M | Sell |
45,903
-225
| -0.5% | -$13.4K | 1.42% | 24 |
|
|
2013
Q2 | $2.37M | Buy |
+46,128
| New | +$2.4M | 1.25% | 25 |
|
Other funds holding GILD
VCM
VPM
Van Cleef Asset Management's GILD Position: Q1 2026 in Review
Van Cleef Asset Management reduced its Gilead Sciences (GILD) stake by 9.8% in Q1 2026, selling an estimated $75.6K and leaving 4,950 shares worth $690K. The position accounts for 0.07% of the portfolio, ranked #75.
Van Cleef Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.2M in Q3 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Van Cleef Asset Management held 4,950 shares of Gilead Sciences worth $690K as of Q1 2026.
- Van Cleef Asset Management sold 540 Gilead Sciences shares in Q1 2026, an estimated $75.6K.
- Gilead Sciences made up 0.07% of Van Cleef Asset Management's portfolio in Q1 2026, its #75 holding.
- Van Cleef Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Van Cleef Asset Management's Gilead Sciences position peaked at $10.2M in Q3 2018.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Van Cleef Asset Management's 13F filing for Q1 2026, filed 1 May 2026.